Statin Use and the Presence of Microalbuminuria. Results from the ERICABEL Trial: A Non-Interventional Epidemiological Cohort Study

BACKGROUND: Microalbuminuria (MAU) is considered as a predictor or marker of cardiovascular and renal events. Statins are widely prescribed to reduce cardiovascular risk and to slow down progression of kidney disease. But statins may also generate tubular MAU. The current observational study evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Tol, Arjan, Van Biesen, Wim, Van Laecke, Steven, Bogaerts, Kris, De Lombaert, Koen, Warrinnier, Hans, Vanholder, Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281099/
https://www.ncbi.nlm.nih.gov/pubmed/22359611
http://dx.doi.org/10.1371/journal.pone.0031639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281099/
https://www.ncbi.nlm.nih.gov/pubmed/22359611
http://dx.doi.org/10.1371/journal.pone.0031639

Ejemplares similares